Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06396247 · ClinicalTrials.gov registry record · Phase 2

Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance

A Phase 2 study of Mobility Limitation, sponsored by Milton S. Hershey Medical Center.

Recruiting
Registry status
Phase 2
Development phase
360
Enrollment target
2
Study locations

NCT06396247 is a Phase 2 study of Mobility Limitation that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 360 participants, above the 243-participant average among 28 other Mobility Limitation trials with a reported enrollment target (48% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06396247, a Phase 2 study of Mobility Limitation, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.

RECRUITING
Registry status
Phase 2
Development phase
360 participants
Enrollment target
2
Study locations

Study Summary

In this study, we will randomly assign 360 older adults to 12 months of 5 minutes per day of functional resistance training or to a delayed treatment control condition, and measure the impact of the training on measures of lower extremity performance and walking ability.

Conditions Studied

Interventions

  • BEHAVIORAL Functional Activity Strength Training

Study Locations (2)

Pennsylvania

  • Penn State College of Medicine - Hershey
  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2025-04-09
Est. Completion 2028-09
Phase Phase 2

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT06396247

The ClinicalTrials.gov registry entry for NCT06396247 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 243-participant average among 28 other Mobility Limitation trials with a reported enrollment target (48% higher). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mobility Limitation appearing as the primary indexed condition, and to 1 intervention - of which Functional Activity Strength Training is the first listed.

NCT06396247 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06396247 about?

NCT06396247 is a clinical study titled "Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance". In this study, we will randomly assign 360 older adults to 12 months of 5 minutes per day of functional resistance training or to a delayed treatment control condition, and measure the impact of the training on measures of lower extremity performance and walking ability.

What is the current status of trial NCT06396247?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 360 participants. The study started on 2025-04-09. Estimated completion is 2028-09.

What conditions does trial NCT06396247 study?

This clinical trial studies the following conditions: Mobility Limitation.

What interventions are being tested in trial NCT06396247?

The interventions under investigation include: Functional Activity Strength Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06396247?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06396247 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mobility Limitation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.